Characterization of genomic breakpoints in <i>MLL</i> and <i>CBP</i> in leukemia patients with t(11;16)
Yanming Zhang(Xuzhou Medical College), Janet D. Rowley(University of East London), Brigitte Schlegelberger(Heidelberg University), Neelmini Emmanuel(University of Chicago), Loretta S. Li(Northwestern University), Nimanthi Jayathilaka(University of Chicago), Yasuhiko Kaneko(MRC Laboratory of Molecular Biology), Tomohiko Taki(Kyorin University), Mary Beth Neilly(University of Chicago), Jianjun Chen(Shanghai Jiao Tong University), Yasuhide Hayashi(Gunma Children's Medical Center), Pamela L. Strissel(Universitätsklinikum Erlangen), Nancy J. Zeleznik‐Le(Loyola University Chicago), Reiner Strick(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 28
Related Papers
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
|Cell|2017|521
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9
|Nature Genetics|1996|451
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450